Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Wound Repair Regen ; 19(3): 411-9, 2011.
Article in English | MEDLINE | ID: mdl-21518092

ABSTRACT

Glucans are known to promote wound repair. Noncellulosic ß-glucans are recognized as potent immunological activators. ß-Glucans are generally safe and are known to attenuate the rate of postoperative infection. Glyc101 is a particulate ß-glucan isolated from Saccharomyces cerevisiae. In this study, the hypothesis that Glyc101 regulates wound macrophage function was tested. Glyc101 induced tumor necrosis factor (TNF) α transcription in macrophages isolated from murine wound site. Multiplex assay identified interleukin (IL)-10 and TNFα as two cytokines that are induced by Glyc101 in human blood monocyte-derived macrophages. Glyc101-induced TNFα production was observed to be mediated via the TLR-2 and dectin-1 receptors, receptor tyrosine kinases and NFκB activation. In murine wound macrophages, Glyc101 potentiated phorbol 12-myristate 13-acetate-induced respiratory burst. In vivo, implantation of Glyc101-enriched polyvinyl alcohol-sponges at the wound-site induced TNFα expression in macrophages. Consistently, Glyc101 induced TNFα expression in wound-site macrophages isolated from two patients with chronic wounds. These observations establish the translational significance of the net findings of this study. Activation of wound macrophages by Glyc101 represents one of the potential mechanisms by which this ß-glucan may benefit chronic wounds where inefficient inflammatory response is one of the underlying causes of impaired healing.


Subject(s)
Macrophages/metabolism , NF-kappa B/physiology , Signal Transduction/immunology , Tumor Necrosis Factor-alpha/metabolism , Wound Healing/drug effects , beta-Glucans/pharmacology , Animals , Cell Wall/chemistry , Cells, Cultured , Dose-Response Relationship, Drug , Humans , Interleukin-10/metabolism , Lectins, C-Type , Macrophage Activation/immunology , Macrophages/drug effects , Macrophages/immunology , Membrane Proteins/metabolism , Membrane Proteins/pharmacology , Mice , Mice, Inbred C57BL , Nerve Tissue Proteins/metabolism , Nerve Tissue Proteins/pharmacology , Oxidation-Reduction , Phagocytosis/drug effects , Phagocytosis/immunology , Phagocytosis/physiology , Saccharomyces cerevisiae/immunology , Saccharomyces cerevisiae/metabolism , Signal Transduction/drug effects
2.
Nitric Oxide ; 23(4): 311-8, 2010 Dec 15.
Article in English | MEDLINE | ID: mdl-20854922

ABSTRACT

Carbon fiber microelectrodes and carbon fiber composite minielectrodes (CFM/CFCM) have been generally used for measurements of nitric oxide (NO) concentration in chemical and biological systems. The response time of a CFM/CFCM is usually from milliseconds to seconds depending on the electrode size, the thickness of coating layers on the electrode, and NO diffusion coefficients of the coating layers. As a result, the time course of recoded current changes (I-t curves) by the CFM/CFCM may be different from the actual time course of NO concentration changes (c-t curves) if the half-life of NO decay is close to or shorter than the response time of the electrode used. This adds complexity to the process for determining rate constants of NO decay kinetics from the recorded current curves (I-t curves). By computer simulations based on a mathematical model, an approximation method was developed for determining rate constants of NO decay from the recorded current curves. This method was first tested and valuated using a commercial CFCM in several simple reaction systems with known rate constants. The response time of the CFCM was measured as 4.7±0.7 s (n=5). The determined rate constants of NO volatilization and NO autoxidation in our measurement system at 37 °C are (1.9±0.1)×10(-3) s(-1) (n=4) and (2.0±0.3)×10(3) M(-1) s(-1) (n=7), which are close to the reported rate constants. The method was then applied to determine the rate of NO decay in blood samples from control and smoking exposed mice. It was observed that the NO decay rate in the smoking group is >20% higher than that in control group, and the increased NO decay rate in the smoking group was reversed by 10 µM diphenyleneiodonium chloride (DPI), an inhibitor of flavin enzymes such as leukocyte NADPH oxidase.


Subject(s)
Biosensing Techniques/methods , Carbon/chemistry , Nanocomposites/chemistry , Nitric Oxide/analysis , Nitric Oxide/metabolism , Animals , Carbon Fiber , Computer Simulation , Diffusion , Electrodes , Kinetics , Male , Mice , Mice, Inbred C57BL , Models, Animal , Solutions
3.
PLoS One ; 5(3): e9539, 2010 Mar 04.
Article in English | MEDLINE | ID: mdl-20209061

ABSTRACT

BACKGROUND: Chronic inflammation is a characteristic feature of diabetic cutaneous wounds. We sought to delineate novel mechanisms involved in the impairment of resolution of inflammation in diabetic cutaneous wounds. At the wound-site, efficient dead cell clearance (efferocytosis) is a pre-requisite for the timely resolution of inflammation and successful healing. METHODOLOGY/PRINCIPAL FINDINGS: Macrophages isolated from wounds of diabetic mice showed significant impairment in efferocytosis. Impaired efferocytosis was associated with significantly higher burden of apoptotic cells in wound tissue as well as higher expression of pro-inflammatory and lower expression of anti-inflammatory cytokines. Observations related to apoptotic cell load at the wound site in mice were validated in the wound tissue of diabetic and non-diabetic patients. Forced Fas ligand driven elevation of apoptotic cell burden at the wound site augmented pro-inflammatory and attenuated anti-inflammatory cytokine response. Furthermore, successful efferocytosis switched wound macrophages from pro-inflammatory to an anti-inflammatory mode. CONCLUSIONS/SIGNIFICANCE: Taken together, this study presents first evidence demonstrating that diabetic wounds suffer from dysfunctional macrophage efferocytosis resulting in increased apoptotic cell burden at the wound site. This burden, in turn, prolongs the inflammatory phase and complicates wound healing.


Subject(s)
Diabetes Mellitus, Experimental/metabolism , Inflammation , Macrophages/metabolism , Adult , Animals , Apoptosis , Cytokines/metabolism , Fas Ligand Protein/metabolism , Female , Homozygote , Humans , Male , Mice , Middle Aged , Oxidative Stress , Skin/pathology , Wound Healing
4.
Antioxid Redox Signal ; 13(5): 599-606, 2010 Sep 01.
Article in English | MEDLINE | ID: mdl-20095880

ABSTRACT

Carica papaya Linn is widely known as a medicinal fruit. We sought to study a standardized fermented papaya preparation (FPP) for its effects on wound healing in adult obese diabetic (db/db) mice. FPP blunted the gain in blood glucose and improved the lipid profile after 8 weeks of oral supplementation. However, FPP did not influence weight gain during the supplementation period. FPP (0.2 g/kg body weight) supplementation for 8 weeks before wounding was effective in correcting wound closure. Studies on viable macrophages isolated from the wound site demonstrated that FPP supplementation improved respiratory-burst function as well as inducible NO production. Reactive oxygen species support numerous aspects of wound healing; NO availability in diabetic wounds is known to be compromised. Diabetic mice supplemented with FPP showed a higher abundance of CD68 as well as CD31 at the wound site, suggesting effective recruitment of monocytes and an improved proangiogenic response. This work provides the first evidence that diabetic-wound outcomes may benefit from FPP supplementation by specifically influencing the response of wound-site macrophages and the subsequent angiogenic response. Given that FPP has a long track record of safe human consumption, testing of the beneficial effects of FPP on diabetic wound-related outcomes in a clinical setting is warranted.


Subject(s)
Carica , Diabetes Complications/therapy , Fermentation , Fruit/microbiology , Plant Preparations/administration & dosage , Plant Preparations/therapeutic use , Wound Healing/drug effects , Animals , Antigens, CD/genetics , Antigens, Differentiation, Myelomonocytic/genetics , Blood/drug effects , Blood Glucose/drug effects , Blood Glucose/metabolism , Body Weight/drug effects , Diabetes Complications/metabolism , Diabetes Complications/pathology , Diabetes Mellitus/blood , Diabetes Mellitus/genetics , Dietary Supplements , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Gene Expression/drug effects , Gene Expression/genetics , Insulin/blood , Lipids/blood , Lipopolysaccharides/pharmacology , Lipoproteins/blood , Macrophages/drug effects , Macrophages/metabolism , Male , Mice , Mice, Obese , Nitric Oxide/metabolism , Nitric Oxide Synthase Type II/genetics , Plant Preparations/pharmacology , Platelet Endothelial Cell Adhesion Molecule-1/metabolism , Reactive Oxygen Species/metabolism , Superoxides/metabolism , Tetradecanoylphorbol Acetate/pharmacology , Vascular Endothelial Growth Factor A/genetics , Wounds and Injuries/metabolism , Wounds and Injuries/pathology , Wounds and Injuries/therapy
5.
Free Radic Biol Med ; 48(4): 554-9, 2010 Feb 15.
Article in English | MEDLINE | ID: mdl-19969071

ABSTRACT

Endothelium-derived nitric oxide (NO) is critical in maintaining vascular tone. Accumulating evidence shows that NO bioavailability is regulated by oxygen concentration. However, it is unclear to what extent the oxygen concentration regulates NO bioavailability in the vascular wall. In this study, a recently developed experimental setup was used to measure the NO diffusion flux across the aortic wall at various oxygen concentrations. It was observed that for a constant NO concentration at the endothelial surface, the measured NO diffusion flux out of the adventitial surface at [O(2)]=0 microM is around fivefold greater than at [O(2)]=150 microM, indicating that NO is consumed in the aortic wall in an oxygen-dependent manner. Analysis of experimental data shows that the rate of NO consumption in the aortic wall is first order with respect to [NO] and first order with respect to [O(2)], and the rate constant k(1) was determined as (4.0+/-0.3) x 10(3) M(-1) s(-1). Computer simulations demonstrate that NO concentration distribution significantly changes with oxygen concentration and the effective NO diffusion distance at low oxygen level ([O(2)] < or =25 microM) is significantly longer than that at high oxygen level ([O(2)]=200 microM). These results suggest that oxygen-dependent NO consumption may play an important role in dilating blood vessels during hypoxia by increasing the effective NO diffusion distance.


Subject(s)
Aorta/pathology , Endothelium, Vascular/pathology , Nitric Oxide/metabolism , Oxygen/metabolism , Animals , Aorta/metabolism , Computer Simulation , Diffusion , Electrochemistry/methods , Free Radicals , Hypoxia , Kinetics , Models, Theoretical , Nitric Oxide/chemistry , Oxygen/chemistry , Oxygen Consumption , Rats , Rats, Inbred WKY , Tunica Media/pathology
6.
Biophys J ; 94(5): 1880-9, 2008 Mar 01.
Article in English | MEDLINE | ID: mdl-18032554

ABSTRACT

Endogenous nitric oxide (NO) plays important physiological roles in the body. As a small diatomic molecule, NO has been assumed to freely diffuse in tissues with a diffusion rate similar to that in water. However, this assumption has not been tested experimentally. In this study, a modified Clark-type NO electrode attached with a customized aorta holder was used to directly measure the flux of NO diffusion across the aortic wall at 37 degrees C. Experiments were carefully designed for accurate measurements of the apparent NO diffusion coefficient D and the partition coefficient alpha in the aortic wall. A mathematical model was presented for analyzing experimental data. It was determined that alpha = 1.15 +/- 0.11 and D = 848 +/- 45 mum(2)/s (n = 12). The NO diffusion coefficient in the aortic wall is nearly fourfold smaller than the reported diffusion coefficient in solution at 37 degrees C, indicating that NO diffusion in the vascular wall is no longer free, but markedly dependent on the environment in the tissue where these NO molecules are. These results imply that the NO diffusion rate in the vascular wall may be upregulated and downregulated by certain physiological and/or pathophysiological processes affecting the composition of tissues.


Subject(s)
Algorithms , Aorta/metabolism , Endothelium, Vascular/metabolism , Nitric Oxide/blood , Animals , Biological Transport , Diffusion , Kinetics , Microelectrodes , Microscopy , Models, Cardiovascular , Nitric Oxide/pharmacokinetics , Oxygen/metabolism , Permeability , Rats , Rats, Inbred WKY
SELECTION OF CITATIONS
SEARCH DETAIL
...